全文获取类型
收费全文 | 7522篇 |
免费 | 654篇 |
国内免费 | 4篇 |
专业分类
8180篇 |
出版年
2023年 | 58篇 |
2022年 | 143篇 |
2021年 | 273篇 |
2020年 | 147篇 |
2019年 | 176篇 |
2018年 | 199篇 |
2017年 | 160篇 |
2016年 | 335篇 |
2015年 | 509篇 |
2014年 | 521篇 |
2013年 | 532篇 |
2012年 | 755篇 |
2011年 | 645篇 |
2010年 | 375篇 |
2009年 | 363篇 |
2008年 | 489篇 |
2007年 | 417篇 |
2006年 | 375篇 |
2005年 | 287篇 |
2004年 | 288篇 |
2003年 | 262篇 |
2002年 | 238篇 |
2001年 | 52篇 |
2000年 | 29篇 |
1999年 | 39篇 |
1998年 | 60篇 |
1997年 | 29篇 |
1996年 | 22篇 |
1995年 | 27篇 |
1994年 | 23篇 |
1993年 | 27篇 |
1992年 | 23篇 |
1991年 | 19篇 |
1990年 | 14篇 |
1989年 | 21篇 |
1988年 | 12篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 12篇 |
1984年 | 15篇 |
1983年 | 24篇 |
1982年 | 8篇 |
1981年 | 16篇 |
1980年 | 13篇 |
1979年 | 11篇 |
1978年 | 15篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1974年 | 8篇 |
排序方式: 共有8180条查询结果,搜索用时 15 毫秒
81.
María Fernanda Lammoglia Cobo Julia Ritter Regina Gary Volkhard Seitz Josef Mautner Michael Aigner Simon Vlkl Stefanie Schaffer Stephanie Moi Anke Seegebarth Heiko Bruns Wolf Rsler Kerstin Amann Maike Büttner-Herold Steffen Hennig Andreas Mackensen Michael Hummel Andreas Moosmann Armin Gerbitz 《PLoS pathogens》2022,18(4)
Reconstitution of the T cell repertoire after allogeneic stem cell transplantation is a long and often incomplete process. As a result, reactivation of Epstein-Barr virus (EBV) is a frequent complication that may be treated by adoptive transfer of donor-derived EBV-specific T cells. We generated donor-derived EBV-specific T cells by stimulation with peptides representing defined epitopes covering multiple HLA restrictions. T cells were adoptively transferred to a patient who had developed persisting high titers of EBV after allogeneic stem cell transplantation for angioimmunoblastic T-cell lymphoma (AITL). T cell receptor beta (TCRβ) deep sequencing showed that the T cell repertoire of the patient early after transplantation (day 60) was strongly reduced and only very low numbers of EBV-specific T cells were detectable. Manufacturing and in vitro expansion of donor-derived EBV-specific T cells resulted in enrichment of EBV epitope-specific, HLA-restricted T cells. Monitoring of T cell clonotypes at a molecular level after adoptive transfer revealed that the dominant TCR sequences from peptide-stimulated T cells persisted long-term and established an EBV-specific TCR clonotype repertoire in the host, with many of the EBV-specific TCRs present in the donor. This reconstituted repertoire was associated with immunological control of EBV and with lack of further AITL relapse. 相似文献
82.
Ammar Jabali Anne Hoffrichter Ana Uzquiano Fabio Marsoner Ruven Wilkens Marco Siekmann Bettina Bohl Andrea C Rossetti Sandra Horschitz Philipp Koch Fiona Francis Julia Ladewig 《EMBO reports》2022,23(5)
Malformations of human cortical development (MCD) can cause severe disabilities. The lack of human‐specific models hampers our understanding of the molecular underpinnings of the intricate processes leading to MCD. Here, we use cerebral organoids derived from patients and genome edited‐induced pluripotent stem cells to address pathophysiological changes associated with a complex MCD caused by mutations in the echinoderm microtubule‐associated protein‐like 1 (EML1) gene. EML1‐deficient organoids display ectopic neural rosettes at the basal side of the ventricular zone areas and clusters of heterotopic neurons. Single‐cell RNA sequencing shows an upregulation of basal radial glial (RG) markers and human‐specific extracellular matrix components in the ectopic cell population. Gene ontology and molecular analyses suggest that ectopic progenitor cells originate from perturbed apical RG cell behavior and yes‐associated protein 1 (YAP1)‐triggered expansion. Our data highlight a progenitor origin of EML1 mutation‐induced MCD and provide new mechanistic insight into the human disease pathology. 相似文献
83.
84.
85.
86.
87.
88.
89.
Laura Stanbery Nisha J D'Silva Julia S Lee Carol R Bradford Thomas E Carey Mark E Prince Gregory T Wolf Francis P Worden Kitrina G Cordell Elizabeth M Petty 《Translational oncology》2010,3(4):239-245
The purpose of this work was to determine SEPT9_v1 expression levels in head and neck squamous cell carcinoma (HNSCC) and to analyze whether SEPT9_v1 expression is relevant to clinical outcomes. Recently, the SEPT9 isoform SEPT9_v1 has been implicated in oncogenesis, and methylation of the SEPT9 promoter region was reported in HNSCC. These findings led us to hypothesize that SEPT9_v1 could be differently expressed in HNSCC. To determine whether SEPT9_v1 is expressed in HNSCC, tissue microarray immunohistochemical analysis was performed using a SEPT9_v1-specific antibody. Tissue microarrays stained with a polyclonal SEPT9_v1-specific antibody was used to determine protein expression levels in HNSCC tissue samples, some with known clinical outcomes. This analysis showed that SEPT9_v1 is in fact highly expressed in HNSCC compared with normal epithelium, and high expression levels directly correlated with poor clinical outcomes. Specifically, a high SEPT9_v1 expression was associated with decreased disease-specific survival (P = .012), time to indication of surgery at primary site (P = .008), response to induction chemotherapy (P = .0002), and response to chemotherapy (P = .02), as well as advanced tumor stage (P = .012) and N stage (P = .0014). The expression of SEPT9_v1 was also strongly correlated with smoking status (P = .00094). SEPT9_v1 is highly expressed in HNSCC, and a high expression of SEPT9_v1 is associated with poor clinical outcomes. These data indicate that SEPT9_v1 warrants additional investigation as a potential biomarker for HNSCC. 相似文献
90.